Vascularization of hollow channel-modified porous silk scaffolds with endothelial cells for tissue regeneration

Biomaterials

Volumn 56, Issue , 2015, Pages 68-77

  Zhang, Wenjie ^a   Wray, Lindsay S ^b   Rnjak Kovacina, Jelena ^b   Xu, Ling ^a   Zou, Duohong ^c   Wang, Shaoyi ^a   Zhang, Maolin ^a   Dong, Jiachen ^a   Li, Guanglong ^a   Kaplan, David L ^b   Jiang, Xinquan ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b Tufts University   (United States)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Cell survival; Cell tracking; Regenerative medicine; Silk fibroin; Vascularization

Indexed keywords

CELL ENGINEERING; CELL PROLIFERATION; CYTOLOGY; ENDOTHELIAL CELLS; REGENERATIVE MEDICINE; STEM CELLS; TISSUE;

CELL SURVIVAL; CELL TRACKING; CLINICAL APPLICATION; SILK FIBROIN; TISSUE CONSTRUCTS; TRANSPLANTED CELLS; VASCULARIZATION; VASCULARIZATION PROCESS;

SCAFFOLDS (BIOLOGY);

SILK FIBROIN; VASCULOTROPIN; BIOMATERIAL; FIBROIN; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ARTICLE; CELL DENSITY; CELL GROWTH; CELL SURVIVAL; CELL TRACKING; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HOLLOW CHANNEL MODIFIED POROUS SILK SCAFFOLD; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE SCAFFOLD; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION; ANGIOGENESIS; ANIMAL; BAGG ALBINO MOUSE; BOMBYX; BONE MARROW CELL; CELL TRANSPLANTATION; CHEMISTRY; CYTOLOGY; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; NUDE MOUSE; POROSITY; PROCEDURES; REGENERATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; BOMBYX; BONE MARROW CELLS; CELL SURVIVAL; CELL TRANSPLANTATION; FIBROINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; POROSITY; REGENERATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; X-RAY MICROTOMOGRAPHY;

EID: 84928396541     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.03.053     Document Type: Article

References (47)

1. Bianco P., Robey P.G. Stem cells in tissue engineering. Nature 2001, 414:118-121.
2. Kaigler D., Pagni G., Park C.H., Braun T.M., Holman L.A., Yi E., et al. Stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trial. Cell Transpl 2013, 22:767-777.
3. Petite H., Viateau V., Bensaid W., Meunier A., De Pollak C., Bourguignon M., et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000, 18:959-963.
4. Lutolf M.P., Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotech 2005, 23:47-55.
5. Lutolf M.P., Gilbert P.M., Blau H.M. Designing materials to direct stem-cell fate. Nature 2009, 462:433-441.
6. Discher D.E., Mooney D.J., Zandstra P.W. Growth factors, matrices, and forces combine and control stem cells. Science 2009, 324:1673.
7. Zhang W., Wang G., Liu Y., Zhao X., Zou D., Zhu C., et al. The synergistic effect of hierarchical micro/nano-topography and bioactive ions for enhanced osseointegration. Biomaterials 2013, 34:3184-3195.
8. Laschke M.W., Harder Y., Amon M., Martin I., Farhadi J., Ring A., et al. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng 2006, 12:2093-2104.
9. Lovett M., Lee K., Edwards A., Kaplan D.L. Vascularization strategies for tissue engineering. Tissue Eng Part B Rev 2009, 15:353-370.
10. Wray L., Tsioris K., Gi E., Omenetto F., Kaplan D. Slowly degradable porous silk microfabricated scaffolds for vascularized tissue formation. Adv Funct Mater 2013, 23:3404-3412.
11. Omenetto F.G., Kaplan D.L. New opportunities for an ancient material. Science 2010, 329:528-531.
12. Altman G.H., Diaz F., Jakuba C., Calabro T., Horan R.L., Chen J., et al. Silk-based biomaterials. Biomaterials 2003, 24:401-416.
13. Wray L.S., Rnjak-Kovacina J., Mandal B.B., Schmidt D.F., Gil E.S., Kaplan D.L. Asilk-based scaffold platform with tunable architecture for engineering critically-sized tissue constructs. Biomaterials 2012, 33:9214-9224.
14. Rnjak-Kovacina J., Wray L.S., Golinski J.M., Kaplan D.L. Arrayed hollow channels in silk-based scaffolds provide functional outcomes for engineering critically sized tissue constructs. Adv Funct Mater 2013, 24:2188-2196.
15. Unger R.E., Sartoris A., Peters K., Motta A., Migliaresi C., Kunkel M., et al. Tissue-like self-assembly in cocultures of endothelial cells and osteoblasts and the formation of microcapillary-like structures on three-dimensional porous biomaterials. Biomaterials 2007, 28:3965-3976.
16. Hutton D.L., Grayson W.L. Stem cell-based approaches to engineering vascularized bone. Curr Opin Chem Eng 2014, 3:75-82.
17. Rockwood D.N., Preda R.C., Yücel T., Wang X., Lovett M.L., Kaplan D.L. Materials fabrication from Bombyx mori silk fibroin. Nat Protoc 2011, 6:1612-1631.
18. Nazarov R., Jin H.-J., Kaplan D.L. Porous 3-D scaffolds from regenerated silk fibroin. Biomacromolecules 2004, 5:718-726.
19. Zhang W., Li Z., Liu Y., Ye D., Li J., Xu L., et al. Biofunctionalization of a titanium surface with a nano-sawtooth structure regulates the behavior of rat bone marrow mesenchymal stem cells. Int J Nanomed 2012, 7:4459-4472.
20. Zhang W., Li Z., Huang Q., Xu L., Li J., Jin Y., et al. Effects of a hybrid micro/nanorod topography-modified titanium implant on adhesion and osteogenic differentiation in rat bone marrow mesenchymal stem cells. Int J Nanomed 2013, 8:257-265.
21. Zhang W., Zhu C., Ye D., Xu L., Zhang X., Wu Q., et al. Porous silk scaffolds for delivery of growth factors and stem cells to enhance bone regeneration. PLoS One 2014, 9:e102371.
22. Zhang W., Zhu C., Wu Y., Ye D., Wang S., Zou D., et al. VEGF and BMP-2 promote bone regeneration by facilitating bone marrow stem cell homing and differentiation. Eur Cell Mater 2014, 27:1-12.
23. Zhang W., Jin Y., Qian S., Li J., Chang Q., Ye D., et al. Vacuum extraction enhances rhPDGF-BB immobilization on nanotubes to improve implant osseointegration in ovariectomized rats. Nanomedicine NBM 2014, 10:1809-1818.
24. Zhang W., Wang X., Wang S., Zhao J., Xu L., Zhu C., et al. The use of injectable sonication-induced silk hydrogel for VEGF165 and BMP-2 delivery for elevation of the maxillary sinus floor. Biomaterials 2011, 32:9415-9424.
25. Novosel E.C., Kleinhans C., Kluger P.J. Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev 2011, 63:300-311.
26. Rouwkema J., Rivron N.C., van Blitterswijk C.A. Vascularization in tissue engineering. Trends Biotechnol 2008, 26:434-441.
27. Kneser U., Stangenberg L., Ohnolz J., Buettner O., Stern-Straeter J., Möbest D., et al. Evaluation of processed bovine cancellous bone matrix seeded with syngenic osteoblasts in a critical size calvarial defect rat model. JCell Mol Med 2006, 10:695-707.
28. Santos M.I., Reis R.L. Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. Macromol Biosci 2010, 10:12-27.
29. Levenberg S., Rouwkema J., Macdonald M., Garfein E.S., Kohane D.S., Darland D.C., et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 2005, 23:879-884.
30. Chiu L.L., Radisic M. Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues. Biomaterials 2010, 31:226-241.
31. Hardy J.G., Scheibel T.R. Composite materials based on silk proteins. Prog Polym Sci 2010, 35:1093-1115.
32. Wenk E., Merkle H.P., Meinel L. Silk fibroin as a vehicle for drug delivery applications. JControl Release 2011, 150:128-141.
33. Mandal B.B., Kundu S.C. Cell proliferation and migration in silk fibroin 3D scaffolds. Biomaterials 2009, 30:2956-2965.
34. Chen D.-Y., Wei H.-J., Lin K.-J., Huang C.-C., Wang C.-C., Wu C.-T., et al. Three-dimensional cell aggregates composed of HUVECs and cbMSCs for therapeutic neovascularization in a mouse model of hindlimb ischemia. Biomaterials 2013, 34:1995-2004.
35. Santos M.I., Tuzlakoglu K., Fuchs S., Gomes M.E., Peters K., Unger R.E., et al. Endothelial cell colonization and angiogenic potential of combined nano-and micro-fibrous scaffolds for bone tissue engineering. Biomaterials 2008, 29:4306-4313.
36. Tsigkou O., Pomerantseva I., Spencer J.A., Redondo P.A., Hart A.R., O'Doherty E., et al. Engineered vascularized bone grafts. Proc Natl Acad Sci U S A 2010, 107:3311-3316.
37. Lokmic Z., Mitchell G.M. Engineering the microcirculation. Tissue Eng Part B Rev 2008, 14:87-103.
38. Seghezzi G., Patel S., Ren C.J., Gualandris A., Pintucci G., Robbins E.S., et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. JCell Biol 1998, 141:1659-1673.
39. Leung D.W., Cachianes G., Kuang W.-J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309.
40. Yamagishi S.-i., Yonekura H., Yamamoto Y., Katsuno K., Sato F., Mita I., et al. Advanced glycation end products-driven angiogenesis invitro induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. JBiol Chem 1997, 272:8723-8730.
41. Byrne A.M., Bouchier-Hayes D., Harmey J. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). JCell Mol Med 2005, 9:777-794.
42. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. JCell Physiol 2007, 213:341-347.
43. Bianco P., Cao X., Frenette P.S., Mao J.J., Robey P.G., Simmons P.J., et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med 2013, 19:35-42.
44. Oswald J., Boxberger S., Jørgensen B., Feldmann S., Ehninger G., Bornhäuser M., et al. Mesenchymal stem cells can be differentiated into endothelial cells invitro. Stem Cells 2004, 22:377-384.
45. Aranguren X.L., Luttun A., Clavel C., Moreno C., Abizanda G., Barajas M.A., et al. Invitro and invivo arterial differentiation of human multipotent adult progenitor cells. Blood 2007, 109:2634-2642.
46. Choi K.D., Yu J., Smuga-Otto K., Salvagiotto G., Rehrauer W., Vodyanik M., et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 2009, 27:559-567.
47. Jung Y., Bauer G., Nolta J.A. Concise Review: Induced pluripotent stem Cell-Derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells 2012, 30:42-47.